Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours
More than ten years of published clinical data and personal experience using peptide receptor radionuclide…
Browsing: Peptide Receptor Radionuclide Therapy (PRRT)
Targeted hormone-radiation treatment slows growth of midgut neuroendocrine tumours
Early results from a phase III study of patients with previously treated, advanced midgut neuroendocrine…